Author:
Razova O. A.,Afanas’eva O. I.,Egiazaryan M. G.,Sherstyuk E. E.,Klesareva E. A.,Pokrovskii S. N.
Publisher
Springer Science and Business Media LLC
Subject
General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference15 articles.
1. Afanasieva OI, Ezhov MV, Pokrovsky SN. Antisense oligo-nucleotides and therapeutical monoclonal antibodies as a basement for novel biological lipidlowering drugs. Ross. Kardiol. Zh. 2018;23(8):99-109. Russian.
2. Afanasieva OI, Razova OA, Utkina EA, Afanasieva MI, Klesareva EA, Popova AB, Ezov MV, Pokrovsky SN. The relationship between the PCSK9 and lipoprotein(a) concentrations in patients with severe hypercholesterolemia depending on the apolipoprotein(a) phenotype. Kardiol. Vestn. 2018;13(1):45-50. Russian.
3. Tmoyan NA, Ezhov MV, Afanasieva OI, Klesareva EA, Razova OA, Kukharchuk VV, Pokrovsky SN. The association of lipoprotein(a) and apolipoprotein(a) phenotypes with peripheral artery disease. Ter. Arkh. 2018;90(9):31-36. Russian.
4. Afanasieva OI, Ezhov MV, Razova OA, Afanasieva MI, Utkina EA, Pokrovsky SN. Apolipoprotein(a) phenotype determines the correlations of lipoprotein(a) and proprotein convertase subtilisin/kexin type 9 levels in patients with potential familial hypercholesterolemia. Atherosclerosis. 2018;277:477-482. doi: https://doi.org/10.1016/j.atherosclerosis.2018.08.011
5. Cao YX, Liu HH, Sun D, Jin JL, Xu RX, Guo YL, Wu NQ, Zhu CG, Li S, Zhang Y, Sun J, Li JJ. The different relations of PCSK9 and Lp(a) to the presence and severity of atherosclerotic lesions in patients with familial hypercholesterolemia. Atherosclerosis. 2018;277:7-14. doi: https://doi.org/10.1016/j.atherosclerosis.2018.07.030
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献